CLOV vs GRAL · rev $1.37B vs rev $125.6M
Clover Health Investments Corp (CLOV) versus GRAIL, LLC (GRAL) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
GRAIL, LLC (GRAL) is a diagnostics & research company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported GRAL revenue for 2024-12-31 was $125.6M. Net income was -$2.03B. Revenue was up 34.9% from 2023-12-31 to 2024-12-31. GRAL currently screens at market cap $2.57B.
CLOV currently screens at market cap $1.55B. GRAL currently screens at market cap $2.57B.
Not investment advice. Open the CLOV and GRAL stock pages for the full models.
Not investment advice.